MedPath
HSA Approval

FERROCYTE TABLET 50 mg

SIN06142P

FERROCYTE TABLET 50 mg

FERROCYTE TABLET 50 mg

June 17, 1991

EISAI (SINGAPORE) PTE. LTD.

EISAI (SINGAPORE) PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantEISAI (SINGAPORE) PTE. LTD.
Licence HolderEISAI (SINGAPORE) PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

B03AB01

ferric sodium citrate

Manufacturer Information

EISAI (SINGAPORE) PTE. LTD.

SANNOVA CO LTD

Active Ingredients

SODIUM FERROUS CITRATE EQV ELEMENTAL IRON

50 mg

Iron

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

FERROCYTE TABLET 50 mg - HSA Approval | MedPath